You are here

Article info

Article menu

Download PDFPDF

Benefits to nonparticipants
Paper
Contractualist reasoning, HIV cure clinical trials, and the moral (ir)relevance of the risk/benefit ratio

Authors

  1. Correspondence to Dr Rahul Kumar, Department of Philosophy, Queen's University, Kingston, Ontario, Canada K7L 3N6; rahul.kumar{at}queensu.ca
View Full Text

Citation

Kumar R
Contractualist reasoning, HIV cure clinical trials, and the moral (ir)relevance of the risk/benefit ratio
Journal of Medical Ethics 2017;43:124-127.

Publication history

  • Received January 18, 2016
  • Revised August 11, 2016
  • Accepted August 17, 2016
  • First published September 2, 2016.
Online issue publication 
January 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Other content recommended for you